Phase II study of oxaliplatin and capecitabine in advanced head and neck malignancies.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Oxaliplatin
- Indications Head and neck cancer
- Focus Therapeutic Use
- 03 Sep 2020 Biomarkers information updated
- 27 Apr 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 27 Apr 2012 Actual patient number is 17 according to ClinicalTrials.gov.